OLDWICK, N.J.–(BUSINESS WIRE)–The September issue of Best’s Review includes the following exclusive rankings:Top 25 US Property/Casualty Mutual WritersTop 25 US Life/Health Mutual CompaniesTop Global Reinsurance GroupsUS P/C D&O Monoline WritersUS Life/Health – 2025:Individual Life Average Policy Size and Lapse RatiosGroup Life IssuedGroup Life In ForceTotal Life IssuedTotal Life In ForceOrdinary Life IssuedOrdinary Life In ForceTerm Life IssuedTerm Life In ForceBest’s Review is AM Best’s

LONDON & DENVER–(BUSINESS WIRE)–Janus Henderson Investors today announced two senior investment appointments that will further deepen the firm’s leadership across its global equities franchise. Helen Jewell will join the firm as Head of EMEA & Asia Pacific Equities on December 1, 2026, and she will be based in London. Shilpee Raina will join as Lead Portfolio Manager of the flagship large cap growth fund, Janus Henderson Forty, as well as the Transformational Growth ETF (JXX), working wit

LONDON–(BUSINESS WIRE)–  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari

LIVINGSTON, N.J.–(BUSINESS WIRE)–CoreWeave, Inc. (Nasdaq: CRWV) (“CoreWeave”) announced today the pricing of its private offering of $3.7 billion aggregate principal amount of its 2.875% convertible senior notes due 2033 (the “Notes”). The offering was upsized from the previously announced offering of $3.0 billion aggregate principal amount of Notes. The issuance and sale of the Notes are scheduled to settle on September 22, 2026, subject to customary closing conditions. CoreWeave also grante

WASHINGTON–(BUSINESS WIRE)–CAVA Group, Inc. (NYSE: CAVA), today announced that its board of directors approved a share repurchase program with authorization to purchase up to $100 million of its outstanding shares of common stock. Repurchases under the program may be made in the open market, in privately negotiated transactions or by other means, including through trading plans intended to qualify under Rule 10b5-1 of the Securities Exchange Act of 1934, with the amount and timing of repurcha

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.